Clinical Trial Update: Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial completed evaluating the effects of delta-9-tetrahydrocannabinol (THC) on retention of fear extinction memory in individuals with posttra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Delta-9-tetrahydrocannabinol (THC) (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: Wayne State University | Conditions: Posttraumatic Stress Disorder | Phase 1 | Status: COMPLETED